News and Trends 1 Dec 2022
FDA clears SparingVision’s investigational new drug application to treat ocular diseases
…treatments for ocular diseases, lead gene independent therapy for the treatment of retinitis pigmentosa (RP), a form of rod-cone dystrophy (RCD) and the most prevalent inherited retinal disease (IRD). SparingVision…